Skip to main content

Thorburn James M's Form 4 filing

Twist Bioscience Corp (TWST) · filed May 24, 2022

Accession no.
0001214659-22-007387
Filed
May 24, 2022
Trade date
May 20-23, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 10 non-derivative transactions and 3 derivative transactions. Open-market sales total $272.5K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Thorburn James MCIK 0001252038Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 20, 2022Common StockFTax withholdingDisposed−1,027$36.99−$37,988.7345,386Direct
May 20, 2022Common StockMOption exerciseAcquired+3,503$11.59+$40,599.7748,889Direct
May 20, 2022Common StockMOption exerciseAcquired+1,517$26.66+$40,443.2250,406Direct
May 20, 2022Common StockMOption exerciseAcquired+1,600$23.33+$37,32852,006Direct
May 20, 2022Common StockSSaleDisposed−1,850$35.04F3−$64,82450,156Direct
May 20, 2022Common StockSSaleDisposed−2,526$35.88F4−$90,632.8847,630Direct
May 20, 2022Common StockSSaleDisposed−2,101$36.92F5−$77,568.9245,529Direct
May 20, 2022Common StockSSaleDisposed−143$37.72F6−$5,393.9645,386Direct
May 23, 2022Common StockSSaleDisposed−406$36.55F7−$14,839.344,980Direct
May 23, 2022Common StockSSaleDisposed−517$37.18F8−$19,222.0644,463Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 20, 2022Common StockMOption exerciseDisposed−3,503$0.00$022,324Direct
May 20, 2022Common StockMOption exerciseDisposed−1,517$0.00$037,347Direct
May 20, 2022Common StockMOption exerciseDisposed−1,600$0.00$022,548Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

Represents the weighted average sales price per share. The shares sold at prices ranging from $34.43 to $35.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F4

Represents the weighted average sales price per share. The shares sold at prices ranging from $35.44 to $36.43 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F5

Represents the weighted average sales price per share. The shares sold at prices ranging from $36.44 to $37.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F6

Represents the weighted average sales price per share. The shares sold at prices ranging from $37.54 to $38.235 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F7

Represents the weighted average sales price per share. The shares sold at prices ranging from $36.01 to $36.94 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F8

Represents the weighted average sales price per share. The shares sold at prices ranging from $37.03 to $37.47 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)